MS/AL Radiation Oncology Research Partnership

MS/AL 放射肿瘤学研究合作伙伴关系

• 批准号: 8309829
• 负责人: James E. Clarkson
• 金额: $ 31.46万
• 依托单位: SINGING RIVER HEALTH SYSTEM
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-15 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8309829
• 关键词: African American; Alabama; Award; Breast; Cancer Center; Cancer Control; Cancer Patient; Caring; Clinical; Clinical Research; Clinical Trials; Collaborations; Colorectal; Communities; Community Clinical Oncology Program; Community Healthcare; Community Outreach; Development; Diagnosis; Early Diagnosis; Elderly; Ensure; Funding; Goals; Government; Grant; Health; Healthcare; Healthcare Systems; Hospitals; Lung; Malignant Neoplasms; Medical Staff; Medical center; Medicine; Minority Groups; Mission; Mississippi; Outcome; Patients; Prevention; Progress Reports; Prostate; Radiation Oncology; Recurrent Malignant Neoplasm; Research; Research Activity; Research Infrastructure; Research Personnel; Rest; Rivers; Services; Site; Social Work; Staging; System; Transportation; Underinsured; Underrepresented Minority; Underserved Population; Uninsured; United States National Institutes of Health; Universities; health disparity; improved; patient population; programs; treatment trial

In 2003, Singing River Hospital System (SRHS) was awarded a 5-year NIH grant which allowed SRHS to build infrastructure and establish a clinical research program aimed at reducing barriers to clinical research for minorities and the underserved. This project will continue the efforts begun with that grant. SRHS will maintain partnerships with the University of Alabama at Birmingham and the University of Mississippi Medical Center. These collaborations provide access to NCI sponsored clinical research trials to cancer patients receiving care at SRHS. The clinical research opportunities available for the cancer patients include prevention studies and treatment trials for common cancers such as breast, lung, prostate and colorectal. SRHS also offers trials for patients facing treatment challenges such as late stage diagnosis, recurrent cancers and those with limited treatment options. More than 76 clinical trials have been opened at SRHS with more than 102 patients accrued to studies during the CDRP grant. NCI funding also provides our hospital system the opportunity to offer our patients services such as transportation, social services and educational programming. These services are benefiting the Singing River Hospital System patients as well as the community at large and national health care. The RCC medical staff provided availability of clinical research at the community level making it integral to the mission of the cancer center. Grant investigators and staff recognize the importance of clinical research and are taking steps to ensure the sustainability of the research office. During this project SRHS will strengthen its clinical research activities while lessening its need for government funding. There are five sustainability options fully detailed in the research plan. They are: 1) Development of the Coastal Research Consortium; 2) Internal Funding; 3) Expansion of clinical research to a system-wide department; 4) Collaboration with UMMC as a community clinical affiliate; and 5) pursue CCOP/MB-CCOP funding with other CDRP sites.

2003年，SING River医院系统(SRHS)获得了一项为期5年的NIH赠款，这笔资金允许SRHS建设基础设施并建立临床研究计划，旨在减少少数族裔和未得到充分服务的人进行临床研究的障碍。该项目将继续利用这笔赠款开始的努力。SRHS将与阿拉巴马大学伯明翰分校和密西西比大学医学中心保持合作伙伴关系。这些合作为在SRHS接受护理的癌症患者提供了NCI赞助的临床研究试验。癌症患者可获得的临床研究机会包括对乳腺癌、肺癌、前列腺癌和结直肠癌等常见癌症的预防研究和治疗试验。SRHS还为面临治疗挑战的患者提供试验，如晚期诊断、复发癌症和治疗选择有限的患者。SRHS已经开始了76项临床试验，在CDRP赠款期间，有102多名患者参与了研究。NCI基金还为我们的医院系统提供了为患者提供交通、社会服务和教育规划等服务的机会。这些服务使歌河医院系统的患者以及整个社区和国家医疗保健受益。RCC医务人员在社区层面提供临床研究，使其成为癌症中心使命的组成部分。格兰特研究人员和工作人员认识到临床研究的重要性，并正在采取措施确保研究办公室的可持续性。在这个项目中，SRHS将加强其临床研究活动，同时减少对政府资金的需求。研究计划中详细列出了五种可持续发展方案。它们是：1)发展沿海研究联盟；2)内部资金；3)将临床研究扩展到系统范围的部门；4)与作为社区临床附属机构的UMMC合作；5)与其他CDRP网站寻求CCOP/MB-CCOP资金。